GPROSZ 40

American Heart Association, American College of Cardiology

No Adverse effect is reported, high tolerability.

• Improves lipid profile and reduces cardiac events.
• Better control on lipid parameter (64%)
• Superior control in dyslipidaemia & other metabolic parameters.
• Excellent choice in ACS and plaque stabilization.